UnitedHealth Group Incorporated (NYSE:UNH) Stake Decreased by Westhampton Capital LLC

Westhampton Capital LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 4th quarter, Holdings Channel reports. The fund owned 3,049 shares of the healthcare conglomerate’s stock after selling 20 shares during the period. Westhampton Capital LLC’s holdings in UnitedHealth Group were worth $1,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the business. Quarry LP lifted its stake in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. RiverFront Investment Group LLC raised its holdings in UnitedHealth Group by 9.9% during the second quarter. RiverFront Investment Group LLC now owns 25,048 shares of the healthcare conglomerate’s stock worth $12,756,000 after purchasing an additional 2,254 shares in the last quarter. Farmers National Bank increased its position in shares of UnitedHealth Group by 15.5% during the 2nd quarter. Farmers National Bank now owns 6,351 shares of the healthcare conglomerate’s stock valued at $3,234,000 after purchasing an additional 851 shares during the period. Brown Financial Advisors acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $2,898,000. Finally, Sanctuary Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth about $61,519,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.8 %

Shares of UnitedHealth Group stock opened at $538.29 on Thursday. The stock has a 50-day simple moving average of $539.43 and a 200-day simple moving average of $565.28. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market cap of $495.38 billion, a price-to-earnings ratio of 34.73, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.83 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.56%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UNH. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.